RxDoctor Payments Data

Salar Deldar, MD

Pain Medicine · Monterey, CANPI 1578799193

Payments from drug & device makers

$7,500in general payments, 2019–2025

Across 289 payments — averaging $25.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Scilex Pharmaceuticals Inc.$681
  • Abbott$645
  • Averitas Pharma Inc.$576
  • Indivior Inc.$340
  • Merz Pharmaceuticals, LLC$232
  • plus $2K from 22 others
$125in research payments, 2019–2025

Across 1 payment — averaging $125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Indivior Inc.$125

What the payments were for

  • Speaking & faculty fees$4917%
  • Food & beverage$7,00993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,500 in reported general payments places this provider in the 75th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California

Medicare billing

Part B allowed, 2024
$2,357,183
Medicare patients
1,468
Services billed
49,700

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin444$6,521
Diclofenac Sodium142$2,985
Pregabalin90$2,207
Meloxicam694$1,935
Cyclobenzaprine Hcl67$1,362
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen81$1,001
Lidocaine11$993
Acetaminophen-CodeineAcetaminophen With Codeine70$798
Buprenorphine Hcl39$744
Celecoxib18$587
Tizanidine Hcl37$361
Methadone Hcl46$323
Duloxetine Hcl20$265
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$200
Tramadol Hcl76$186

Paid to pharmacies, not to this prescriber.

Other pain medicine in Monterey

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →